FINOSE - Nordic cooperation extended to promote patients' access to medicines

30 June 2020 - The latest FINOSE report is used as the basis of all the five Nordic countries in ...

Read more →

Health economic assessment of Ondexxya in life-threatening or uncontrolled bleeding

26 June 2020 - TLV has developed a health economic assessment for the regions of the drug Ondexxya (andexanet alfa).  ...

Read more →

The reimbursement for medicines is expected to decrease by SEK 185 million in 2020

26 June 2020 - Pharmaceutical companies will pay SEK 2.9 billion in reimbursement for medicines covered by side agreements between ...

Read more →

TLV has decided to change the subsidy status for certain drugs

18 June 2020 - TLV has reviewed the subsidy status for drugs that are included in the Swedish Medicines Agency's ...

Read more →

Sweden's cost of medicines is increasing

15 June 2020 - Sweden's costs for medicines have risen by about SEK 1 billion last year. This shows a ...

Read more →

Health economic assessment of Waylivra in familial chylomicronaemia

11 June 2020 - TLV has made a health economic assessment to the regions of the drug Waylivra (volansorsen).  ...

Read more →

Desloratadine new exchange groups

9 June 2020 - As of 1 July, desloratadine will be included as exchange group on the list of products ...

Read more →

Health economic assessment of Polivy in combination with bendamustine and rituximab

5 June 2020 - The treatment is intended for adult patients with diffuse large-cell B-cell lymphomas who relapse or do not ...

Read more →

More patients have access to medicines within the high-cost protection system

2 June 2020 - From today, patients who pick up prescription drugs at pharmacies will be able to switch to ...

Read more →

Health economic assessment of Vimizim in mucopolysaccharidosis type IVA (Morquio A syndrome)

29 May 2020 - TLV has developed a health economic knowledge base for the regions of the drug Vimizim (elosulfase alfa) ...

Read more →

TLV has decided to reconsider the subsidy status for certain drugs

26 May 2020 - TLV initiates a review for review of subsidy status for drugs that are part of one ...

Read more →

Health economic assessment of Bavencio and Inlyta

18 May 2020 - TLV has developed a health economic assessment for the regions regarding the combination of avelumab (Bavencio) and ...

Read more →

Camurus' Buvidal reimbursed in Sweden for the treatment of opioid dependence

14 May 2020 - Buvidal (buprenorphine) prolonged release injection receives reimbursement in Sweden from the 15 May 2020 after approval by ...

Read more →

Health economic assessment of Spravato in treatment resistant depression

14 May 2020 - TLV has developed a health economic knowledge base for the regions for Spravato (esketamine).  ...

Read more →

Health economic assessment of gene therapy Zynteglo in transfusion-dependent beta-thalassemia

11 May 2020 - TLV has developed a health-economic knowledge base for the Zynteglo gene therapy (autologous CD34-positive cells expressing the ...

Read more →